First UK report of successful treatment of Mycobacterium simiae and immune reconstitution inflammatory syndrome in an HIV-seropositive patient

Sexually Transmitted Infections

Volumn 84, Issue 4, 2008, Pages 271-272

  Phillips, D R ^a   Krishnan, H ^b   Watson, J ^b  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ETHAMBUTOL; ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STEROID;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; DISEASE SEVERITY; DRUG MEGADOSE; DRUG SUBSTITUTION; FEMALE; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LIVER BIOPSY; MYCOBACTERIOSIS; MYCOBACTERIUM SIMIAE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SPLENOMEGALY; STEROID THERAPY; TREATMENT OUTCOME; TUBERCULOSIS; ULTRASOUND; UNITED KINGDOM; VIREMIA;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MYCOBACTERIUM INFECTIONS, ATYPICAL; STEROIDS; TREATMENT OUTCOME;

EID: 49049120510     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2008.029900     Document Type: Article

References (9)

1. Patel NC, Minifee PK, Dishop MK, et al. Mycobacterium simiae cervical lymphadenitis. Pediatr Infect Dis J 2007;26:362-3.
2. Braun-Saro B, Esteban J, Jimenez S, et al. Mycobacterium simiae infection in an immune-compromised patient without acquired immunodeficiency syndrome. Clin Infect Dis 2002;34:E26-7.
3. Levy-Frebault V, Pangon B, Bure A, et al. Mycobacterium simiae and Mycobacterium avium-M intracellulare mixed infection in acquired immune deficiency syndrome. J Clin Microbiol 1987;25:154-7.
4. Conger NG, O'Connell RJ, Laurel VL, et al. Mycobacterium simiae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol 2004;25:1050-5.
5. Legrand E, Devallois A, Morgen L, et al. A molecular epidemiological study of Mycobacterium simiae isolated from AIDS patients in Guadeloupe. J Clin Microbiol 2000;38:3080-4.
6. Al-Abdely HM, Revankar SG, Graybill JR. Disseminated Mycobacterium simiae infection in patients with AIDS. J Infect 2000;41:143-7.
7. Valero G, Moreno F, Graybill JR. Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection. Antimicrob Agents Chemother 1994;38:2676-7.
8. Puthanakit T, Oberdorfer P, Ukarapol N, et al. Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection. Pediatr Infect Dis J 2006;25:645-8.
9. Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis 2004;4:557-65.